Target intelligence / Profile preview

Gastric smooth muscle and neural pathways

Molecular classification
Other
01

Overview

Gastric smooth muscle and neural pathways refer to the integrated physiological system responsible for the mechanical processing and transit of food within the stomach (StatPearls: Physiology, Gastrointestinal Motility, 2023). This system comprises the gastric smooth muscle layers, the interstitial cells of Cajal (ICC) which act as electrical pacemakers, and the enteric nervous system (ENS) organized into the myenteric and submucosal plexuses (Huizinga et al., 2014, Nature Reviews Gastroenterology & Hepatology). The coordination of these components allows for gastric accommodation, trituration, and emptying, regulated by neurotransmitters such as acetylcholine, dopamine, and serotonin (NIH: National Institute of Diabetes and Digestive and Kidney Diseases). Dysfunction in these pathways, including loss of ICCs or enteric neuropathy, is a hallmark of motility disorders like gastroparesis and functional dyspepsia (PubMed: PMID 24890131). Pharmacological interventions typically target specific molecular receptors within these pathways, such as the 5-HT4 serotonin receptor or the D2 dopamine receptor, to modulate contractility (PubChem). Because this term describes a broad physiological system rather than a single molecular entity, it is not considered a discrete therapeutic target in drug discovery.

Other names
Enteric nervous systemGastric neuromuscular apparatusMyenteric plexusGastric motility pathways
02

Mechanism of action

Modulation of gastric motility through agonism or antagonism of neurotransmitter receptors (e.g., D2, 5-HT4, M3) or motilin receptors within the enteric nervous system and smooth muscle cells (StatPearls, 2023).

03

Biological functions

Gastric motilityPeristalsisDigestionSignal transduction
04

Disease associations

GastroparesisFunctional dyspepsiaGastroesophageal reflux diseaseIrritable bowel syndrome
05

Safety considerations

QT interval prolongationExtrapyramidal side effectsTardive dyskinesiaAbdominal crampingDiarrhea
06

Interacting drugs

Metoclopramide

5 more in the full profile.

07

Biomarkers

Gastric emptying rate (scintigraphy)Electrogastrography (EGG) rhythmsAntroduodenal manometry pressures

Beyond the preview

Go deeper on Gastric smooth muscle and neural pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gastric smooth muscle and neural pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call